Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
An. acad. bras. ciênc ; 71(2): 265-71, jun. 1999.
Artigo em Inglês | LILACS | ID: lil-234516

RESUMO

In addition to original research, Far-Manguinhos, the Pharmaceutical Division of the Brazilian Ministry of Healthïs Oswaldo Cruz Foundation (FIOCRUZ), devotes major attention to the finalising of products for use in public health campaigns or, under contract, for private industrial development. Emphasis is on standardisation, adequate supply, safety in use and efficacy. Among the products discussed in this summary of some of its activities in the chemical and pharmaceutical fields are medicinal plants Bidens pilosa, Cymbopogon citratus, Copaifera species, mentha crispa, Phyllanthus tenellus Roxb, and other Physllanthus species, insecticidal plants, Lonchocarpus urucu and Quassia amara, and the insect antifeedant plants Carapa guianensis and Peterodon emarginatus.


Assuntos
Academias e Institutos , Fundações , Repelentes de Insetos , Inseticidas , Plantas Medicinais , Tecnologia Farmacêutica , Medicina Herbária
2.
Ciênc. cult. (Säo Paulo) ; 49(5/6): 339-44, Sept.-Dec. 1997. tab, graf
Artigo em Inglês | LILACS | ID: lil-214094

RESUMO

Medicinal plants are widely employed in both rural and urban Brazil, many in accordance with traditional practices that were developed by the native population or were brought to the country by immigrant peoples from Europe, Africa and Asia. Their use in official public health care requires however more than traditional knowledge. Recently published laws which will come into force by the end of the century, require that scientific evidence be brought to support the popular use, that possible toxicity, especially when chronic use is contemplated, be known to the medical profession and that the raw plant material and final formulation have a chemical composition that lies within limits that can be specific and checked by analysis. Clinical evidence of efficacy should be provided and wherever possible some indication of the mechanism of action and what components of the original plant contribute to this action, are desirable. At the same time, once a plant of given chemical compositon is approved for use, then its widespread production must be organized in such a way that suppy of a product of established quality meets the demand.


Assuntos
Humanos , Aprovação de Drogas/legislação & jurisprudência , Extratos Vegetais/farmacologia , Plantas Medicinais/uso terapêutico , Saúde Pública , Brasil , Medicina Tradicional Chinesa , Extratos Vegetais/farmacocinética , Extratos Vegetais/uso terapêutico , Plantas Medicinais/intoxicação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA